Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...

January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) recently approved a new targeted chemotherapy drug for ...

A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the spread of brain proteins believed to be responsible for Parkinson's ...

Jan 17 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca ... an advanced form of breast cancer who had received prior treatment. The list price of Datroway is $4,891. ...

On January 17, 2025, the Food and Drug Administration ... conjugate. This approval marks a significant advancement in the treatment of hormone receptor (HR)-positive, human epidermal growth factor ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

A Pfizer drug recently awarded accelerated FDA approval in colorectal cancer now has additional data showing it met key goals in its pivotal study, results that could support an application ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain ... So, I think that shows a lot promise.” The new drug will carry a list price of $15.50 per pill, making it ...